Perrot Serge, Le Jeunne Claire
Université Paris Descartes, Hôtel Dieu, service de médecine interne et thérapeutique, Inserm U 987, 75004 Paris, France.
Presse Med. 2012 Apr;41(4):422-6. doi: 10.1016/j.lpm.2012.01.004. Epub 2012 Feb 9.
Steroid muscle-related involvement is a frequent but often underestimated adverse effect of steroid treatment. Clinical presentation may differentiate two features: the less frequent, represented by acute myopathy, essentially observed in resuscitation, in patients treated with high dosages, and the more frequent feature, insidious, painless, chronic myopathy, characterized by a progressive proximal deficit. Diagnosis is mostly based on the clinic, muscle biopsy should remain exceptional, performed to detect other myopathies, since there are no specific anatomopathological findings. Muscle enzymes are rarely increased, electrophysiological analyses demonstrate unspecific and variable abnormalities. Pathophysiology of steroid-induced myopathy is multifactorial, related to protein metabolism modifications (change of both metabolism and catabolism), cellular transcription, growth factors (IGF-1, myostatine). Treatment is unspecific, mostly based on the prevention that should firstly consider steroid dosage reduction.
类固醇相关的肌肉受累是类固醇治疗常见但常被低估的不良反应。临床表现可区分两种特征:较不常见的以急性肌病为代表,主要在复苏过程中、接受高剂量治疗的患者中观察到;更常见的特征是隐匿性、无痛性慢性肌病,其特点是进行性近端肌无力。诊断主要基于临床症状,肌肉活检应属例外情况,仅在检测其他肌病时进行,因为不存在特异性的解剖病理学发现。肌肉酶很少升高,电生理分析显示非特异性且多变的异常。类固醇诱导性肌病的病理生理学是多因素的,与蛋白质代谢改变(代谢和分解代谢的变化)、细胞转录、生长因子(胰岛素样生长因子-1、肌肉生长抑制素)有关。治疗无特异性,主要基于预防,首先应考虑减少类固醇剂量。